Invasive fungal diseases are important causes of morbidity and mortality in
immunocompromised patients. Patients with haematological malignancies and solid …

Infection is the leading cause of non-relapse mortality after allogeneic haematopoietic cell
transplantation (HCT). This occurs as a result of dysfunction to the host immune system from …

Background Cytomegalovirus (CMV) reactivation is one of the most common infectious
complications after allogeneic hematopoietic cell transplant (HCT) and may result in …

NK-cells undergo a “licensing” process as they develop into fully-functional cells capable of
efficiently killing targets. NK-cell differentiation is accompanied by an increased surface …

Cell therapy is emerging as a viable therapy to restore neurological function after stroke.
Many types of stem/progenitor cells from different sources have been explored for their …

Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic
stem cell transplantation (allo-HSCT) may be useful to identify subpopulations who might …

Abstract Purpose of Review Cytomegalovirus (CMV) remains a major cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). New …

Umbilical cord blood (UCB) is an important source of hematopoietic stem cells (HSC) for
allogeneic transplantation when HLA-matched sibling and unrelated donors (MUD) are …

Only 30% of patients who require an allogeneic hematopoietic cell transplant will have an
HLA-matched sibling donor. A search for an unrelated donor will be undertaken for patients …

Slow immune reconstitution is a major obstacle to the successful use of allogeneic
hematopoietic cell transplantation (allo-HCT). As matched sibling donor (MSD) allo-HCT is …